BCL2L11 and cardiomyopathy: Medicinal chemistry and SAR analyses helped us to derive BR43, which appears to have little cytostatic or cytotoxic effect but at the same time was able to reduce Bim induction and cardiomyopathy in a clinically relevant mouse model.